Business
CME Group runs futures, options, cash, and over-the-counter markets, plus clearing and market data, across interest rates, equity indexes, FX, agriculture, energy, metals, and cryptocurrencies.
CME grew revenue +6.4% and FCF +16.6%, with very high margins and dividend-heavy cash returns.
The read at a glance✓ Audited against SEC data
- Growth — Revenue +6.4% to $6.52BOK
- Profitability — Net income +15.5% to $4.07BOK
- Cash quality — FCF +16.6% to $4.19BOK
- Margins — Operating margin +73 bps; FCF +564 bpsOK
- Capital — $3.93B dividends vs $4.19B FCFNote
- Insiders — 4 buys / 15 sells; 1 buyerWatch
Where the revenue comes from
Fiscal 2025, as CME GROUP INC. reports it. History and quarterly detail are in the app.
- Clearing and Transaction Fees$5.3B
- MarketData$803.1M
- OtherRevenue$436.4M
Leadership changes
From CME GROUP INC.'s own filings, the day they're filed.
- Lynne C. Fitzpatrick · Chief Executive Officer · appointmenteff. 2026-06-16
- Lynne Fitzpatrick · Chief Financial Officer · appointmenteff. 2023-04-01
- Suzanne Sprague · Director · appointment
Latest filings
- 8-K · Company announcement2026-08-11
- 10-Q · Quarterly report2026-07-24
- 8-K · Company announcement2026-07-22
- 8-K · Company announcement2026-06-17
- 8-K · Company announcement2026-06-10
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CME GROUP INC., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.